Is the dosage of decavatinib tablets one tablet per month? Common misunderstandings among patients

Deucravacitinib (also known as Deucravacitinib) is a new oral selective TYK2 inhibitor mainly used to treat moderate to severe plaque psoriasis. The drug is administered orally daily and offers the advantages of convenience, rapid onset of action and long-term control. However, some patients are prone to misunderstandings about usage and dosage during use, especially the misunderstanding of "one tablet a month", which may seriously affect the treatment effect.

In fact, the recommended standard dose of deuterated colexitinib is 6 mg once daily rather than one tablet per month. Patients should take the medication orally on time every day to maintain a stable blood concentration to achieve optimal efficacy. Some patients may take "one tablet per month" due to improper understanding of the instructions or misunderstanding of incorrect medication recommendations, resulting in insignificant efficacy or even being mistaken for insufficient drug efficacy, thus interrupting treatment or blindly changing medications.

Patients also often mistakenly believe that the drug is a hormone or immunosuppressant, and therefore have concerns about long-term use. In fact, deuterated coxitinib has a unique mechanism of action. It is not an immunosuppressant in the traditional sense, but selectively inhibits the TYK2 pathway and has less impact on the activity of other members of the JAK family. Therefore, it is better than some JAK inhibitors in terms of side effect control. Long-term studies have shown that it is well tolerated and has a low incidence of adverse reactions. Most of the common side effects, such as pharyngitis, rhinitis, and mild diarrhea, can be relieved by themselves.

In summary, the standard usage of deuterated colexitinib is once a day, which is by no means "one tablet a month." Patients should read the instructions carefully before taking the medicine and take it regularly under the guidance of a professional doctor to avoid limited efficacy due to misuse. At the same time, a correct understanding of the drug's mechanism of action and safety will help improve medication compliance and achieve effective long-term control of psoriasis. If you have any questions about medication, you should consult a medical professional in time. It is not recommended to adjust the dosage or frequency by yourself.

Reference materials:https://go.drugbank.com/drugs/DB16650